Acme Ai
A
gs3
200 Words12.5 Marks

Q.Can overuse and free availability of antibiotics without Doctor’s prescription, be contributors to the emergence of drug-resistant diseases in India? What are the available mechanisms for monitoring and control? Critically discuss the various issues involved.

UPSC Mains 2014Science & Technology

Introduction

The rampant overuse and unregulated, over-the-counter availability of antibiotics without a registered medical practitioner's prescription are primary drivers of Antimicrobial Resistance (AMR) in India. According to the World Health Organization (WHO), India is one of the world's largest consumers of antibiotics. This unchecked consumption has accelerated the mutation of pathogens, leading to the rise of multi-drug resistant "superbugs" and posing a severe threat to public health.


Body

I. How Overuse and Free Availability Contribute to Drug Resistance

  • Self-Medication: Due to easy over-the-counter access, citizens frequently purchase antibiotics to treat self-diagnosed, minor viral infections (like the common cold or flu) where antibiotics are completely ineffective, leading to unnecessary exposure and resistance.
  • Incomplete Treatment Courses: Without professional medical guidance, patients often stop taking antibiotics as soon as their symptoms improve, leaving partially resistant bacteria alive to multiply and mutate.
  • Over-Prescription by Healthcare Providers: Defensive medical practices, diagnostic uncertainties, and pressure from patients or pharmaceutical representatives lead doctors to prescribe broad-spectrum antibiotics unnecessarily.
  • Unregulated Agricultural Use: Antibiotics are heavily used as growth promoters and disease preventatives in poultry, livestock, and aquaculture. These resistant bacteria enter the human food chain and environment, compounding the resistance cycle.
  • Substandard Drug Quality: The circulation of low-dosage or counterfeit antibiotics fails to eliminate pathogens completely, actively fostering the survival of drug-resistant strains.
  • Lack of Healthcare Access: In rural and underserved regions, the absence of qualified doctors forces populations to rely on local pharmacists or informal providers who dispense antibiotics indiscriminately.

II. Available Mechanisms for Monitoring and Control

  • National Action Plan on Antimicrobial Resistance (NAP-AMR): Launched in 2017, this comprehensive plan focuses on strengthening surveillance, promoting research, improving infection control, and regulating antibiotic use across human, animal, and environmental sectors (One Health approach).
  • Schedule H1 Regulation: Introduced under the Drugs and Cosmetics Rules, this regulation restricts the sale of critical antibiotics, requiring pharmacies to maintain strict registers of prescriptions and sales. However, enforcement remains weak.
  • AMR Surveillance Networks: The Indian Council of Medical Research (ICMR) established the Antimicrobial Resistance Surveillance and Research Network (AMRSN) to track resistance trends across major hospitals and guide clinical guidelines.
  • Antimicrobial Stewardship Programs (ASPs): Implemented in major healthcare facilities, these programs optimize antibiotic prescribing practices among clinicians.
  • Public Awareness Campaigns: Initiatives like the "Red Line" Campaign—which marks prescription-only antibiotic packaging with a distinct red line—aim to educate consumers against self-medication.
  • Agricultural Guidelines: The Food Safety and Standards Authority of India (FSSAI) has set tolerance limits for antibiotic residues in food products, and the government has banned specific growth promoters like Colistin in animal farming.

III. Critical Issues and Challenges Involved

  • Weak Regulatory Enforcement: Despite the presence of Schedule H1, regulatory oversight of retail pharmacies, especially in rural and semi-urban areas, is highly inadequate, allowing over-the-counter sales to continue unabated.
  • Socio-Economic Barriers: For millions of poor citizens, consulting a doctor for a prescription is financially prohibitive. Buying cheap, over-the-counter antibiotics from a local pharmacy is often seen as the only viable option.
  • Stakeholder Resistance: Pharmaceutical companies and retail chemists often resist stringent sales regulations due to concerns over declining profit margins.
  • Sanitation and Hygiene Deficits: Poor public sanitation, lack of clean drinking water, and inadequate infection control in hospitals accelerate the spread of resistant infections, neutralizing regulatory efforts.
  • Resource Constraints: Developing robust diagnostic infrastructure and implementing comprehensive stewardship programs nationwide require substantial financial and human resources, which are currently lacking in public healthcare.

Conclusion

Addressing the crisis of antibiotic resistance in India requires a balanced, multi-sectoral approach. While existing frameworks like the NAP-AMR and the Red Line campaign are step in the right direction, their success depends on strict regulatory enforcement, improving rural healthcare access, promoting public awareness, and addressing the environmental and agricultural dimensions of AMR under a unified "One Health" framework.